2
Views
4
CrossRef citations to date
0
Altmetric
Original Article

New Drug Combination for the Treatment of Relapsed Brain Tumors in Children

, , , , , & show all
Pages 153-156 | Received 22 Apr 1987, Accepted 30 Nov 1987, Published online: 09 Jul 2009

References

  • Horváth IP, Csétenyi J, Kerpel-Fronius S, Hindy I, Eckhardt S. Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man 1. Metabolism of DBD. Eur J Cancer 1979; 15: 337–344
  • Csétenyi J, Áfra D, Kerpel-Fronius S, Horváth IP, Eckhardt S. The distribution of labeled dibromodulcitol in the central nervous system of patients with brain tumour. EurJ Cancer Clin Oncol 1983; 19: 1389–1392
  • Boczan G. Experiments with dibromodulcitol in malignant brain tumors. Minerva Neurochir 1969; 13: 254–256
  • Burger P C, Mahaley M S, Dubka L, Vogel F S. The morphologic effects of radiation administered therapeutically for intracranial gliomas. Cancer 1979; 44: 1256–1272
  • Afra D, Kocsis B, Dobay J, Eckhardt S. Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas. J Neurosurg 1983; 59: 106–110
  • Eagan R T, Dinapoli R P, Hermann R C, Groover R V, Layton D D, Scott M. Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation. Cancer Treat Rep 1982; 66: 1647–1649

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.